Idenix Pharmaceuticals (IDIX)

[DewDiligence]

IDIX 2008 Goals

[As stated on JPM webcast 8-Jan-2008.]

HIV

--Complete phase-2a IDX899 7-day monotherapy study (in progress); report results at CROI conference in February.

--Start phase-2 IDX899 6-week combination study.

--Partner IDX899 program following phase-2 study.

HCV

--File IND for IDX184 and complete phase-1 trial.

--Start phase-2a study for IDX184 in combination with HCV SoC.

--File IND for HCV protease inhibitor and complete phase-1 trial.